| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10920366 | Radiotherapy and Oncology | 2005 | 4 Pages |
Abstract
Toxicity and functional outcome were evaluated in 199 MSCC-patients irradiated with 1Ã8 Gy. Motor function improved in 54/199 patients (27%). Patients who regained walking ability were 20/78 (26%). Long-term-survivors (â¥12 months) who needed re-irradiation for in-field-recurrence were 19/65 (29%). Acute toxicity was mild, late toxicity not observed. A randomised trial comparing single-fraction RT to multi-fraction RT is mandatory.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Dirk Rades, Lukas J.A. Stalpers, Maarten C.C.M. Hulshof, Oliver Zschenker, Winfried Alberti, Caro C.E. Koning,